Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$42.05 - $47.77 $9,629 - $10,939
229 Added 1.48%
15,715 $684,000
Q1 2022

May 11, 2022

SELL
$40.23 - $47.74 $18,827 - $22,342
-468 Reduced 2.93%
15,486 $684,000
Q4 2021

Feb 15, 2022

SELL
$38.88 - $45.31 $38,724 - $45,128
-996 Reduced 5.88%
15,954 $712,000
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $30,450 - $33,880
785 Added 4.86%
16,950 $656,000
Q2 2021

Aug 13, 2021

SELL
$36.52 - $41.46 $44,444 - $50,456
-1,217 Reduced 7.0%
16,165 $652,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $31,219 - $36,449
-911 Reduced 4.98%
17,382 $630,000
Q4 2020

Feb 12, 2021

SELL
$34.07 - $39.94 $78,122 - $91,582
-2,293 Reduced 11.14%
18,293 $684,000
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $9,908 - $11,177
-260 Reduced 1.25%
20,586 $785,000
Q2 2020

Aug 13, 2020

BUY
$37.87 - $43.58 $17,382 - $20,003
459 Added 2.25%
20,846 $860,000
Q1 2020

May 20, 2020

BUY
$32.47 - $48.83 $51,854 - $77,981
1,597 Added 8.5%
20,387 $783,000
Q4 2019

Feb 13, 2020

SELL
$42.0 - $48.25 $4,704 - $5,404
-112 Reduced 0.59%
18,790 $892,000
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $485 - $522
12 Added 0.06%
18,902 $815,000
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $58,312 - $63,196
1,480 Added 8.5%
18,890 $755,000
Q1 2019

May 13, 2019

BUY
$38.57 - $42.69 $4,358 - $4,823
113 Added 0.65%
17,410 $727,000
Q4 2018

Feb 13, 2019

BUY
$37.8 - $42.69 $15,119 - $17,076
400 Added 2.37%
17,297 $660,000
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $3,935 - $4,226
99 Added 0.59%
16,897 $678,000
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $8,436 - $9,107
213 Added 1.28%
16,798 $677,000
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $7,887 - $8,752
218 Added 1.33%
16,585 $647,000
Q4 2017

Feb 14, 2018

SELL
$35.34 - $41.9 $22,723 - $26,941
-643 Reduced 3.78%
16,367 $580,000
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $670,874 - $706,765
17,010
17,010 $690,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.